stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Shares outstanding
MiniMed Group, Inc.'s shares outstanding at the end of fiscal 2026 was $256.6M, unchanged from fiscal 2025. At the end of the quarter to 31 July 2026 it was $281.0M. MiniMed Group, Inc. ranks 7th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $256.6M | 1.50% |
| FY2025 | $252.8M | 0.00% |
| FY2024 | $252.8M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jul 2026 | $281.0M | 11.15% |
| Jan 2026 | $252.8M | 0.01% |
| Jul 2025 | $252.8M | (0.01%) |
| Jan 2025 | $252.8M | — |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $361.5M |
| MMED MiniMed Group, Inc. | $281.0M |
| STVN Stevanato Group S.p.A. compare | $273.1M |
| NVST Envista Holdings Corporation compare | $163.4M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| ATRC AtriCure, Inc. compare | $49.8M |
| TFX Teleflex Incorporated compare | $43.7M |
| ICUI ICU Medical, Inc. compare | $25.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement